ABSTRACT
Background
Retinal capillary hemangioblastoma (RCH), while sporadic in some cases, is the most common and earliest manifestation of von Hippel-Lindau disease (VHL). This is the first report on different types of VHL variants and genotype-phenotype correlations in Iranian families with RCH.
Materials and methods
In this prospective observational case series study, 17 families with RCH were included. PCR was performed to amplify 3 exons of VHL gene. Afterward, Sanger sequencing was performed on all PCR products. For the detection of VHL copy number variations, MLPA was used.
Results
Our study identified 10 different types of VHL variants. Missense mutations were the most common variants found and affected the structure of α domain of the VHL protein (pVHL). The majority of mutations (72.7%) in the patients with RCH and central nervous system hemangioblastoma (CNS-HB) were located on α domain.
Conclusion
α domain of VHL may play a potential role in the pathogenesis of RCH. Our findings suggest that genotype-phenotype characteristics in those variants in α- domain may predispose patients to RCH with CNS-HB.
KEYWORDS:
List of abbreviations
(RCH) | = | Retinal capillary hemangioblastoma |
(VHL) | = | von Hippel-Lindau disease |
(pVHL) | = | VHL protein |
(CNS-HB) | = | Central nervous system hemangioblastoma |
(RCC) | = | Cclear cell renal carcinoma |
(ELST) | = | Endolymphatic sac tumor |
(PCC) | = | Pheochromocytomas |
(PC) | = | Pancreatic |
(KC) | = | Kidney cysts |
(HIF) | = | Hypoxia-inducible factors |
(VEGF) | = | Vascular endothelial growth factor |
(PDGF) | = | Platelet-derived growth factor |
(CCT) | = | Chaperonin-containing tailless complex polypeptide 1 |
Disclosure statement
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.
Author’s contributions
M.N. designed the study and finalized the manuscript; F.A. wrote the main manuscript text, performed genetic analysis, genetic tests and interpretation of data; S.T. designed the study and assisted in the genetic analyses; A.S. designed the study; R.M. commented on and revised the manuscript; R.K. collected samples; Z.A. performed genetic tests; G.KH. Supervised the study and commented on the manuscript. All authors read and approved the final version.
Code availability
Ethics code: IR.IUMS.REC.1399.109
Consent for publication
All authors and patients
Consent to participate
Informed consent was obtained from the parents or guardians of all patients who participated in the study.
Availability of data and materials
All datasets generated for this study are included in the article.